CT-2584 phospholipid composition modulator: CTIC began open-label U.S. efficacy testing

Cell Therapeutics Inc. (CTIC), Seattle, Wash. Product: CT-2584 phospholipid composition modulator Indication: Treat advanced prostate cancer Status: CTIC began open-label U.S. efficacy testing in 80 p...